These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7888034)

  • 1. Effect of CD28 antibody on T cells from patients with systemic lupus erythematosus.
    Alvarado C; Alcocer-Varela J; Llorente L; Richaud-Patin Y; Cerbon M; Alarcon-Segovia D
    J Autoimmun; 1994 Dec; 7(6):763-73. PubMed ID: 7888034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imbalance between CD8
    Minning S; Xiaofan Y; Anqi X; Bingjie G; Dinglei S; Mingshun Z; Juan X; Xiaohui J; Huijuan W
    Lupus; 2019 Sep; 28(10):1214-1223. PubMed ID: 31399013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The spliceosomal autoantigen heterogeneous nuclear ribonucleoprotein A2 (hnRNP-A2) is a major T cell autoantigen in patients with systemic lupus erythematosus.
    Fritsch-Stork R; Müllegger D; Skriner K; Jahn-Schmid B; Smolen JS; Steiner G
    Arthritis Res Ther; 2006; 8(4):R118. PubMed ID: 16859514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased interleukin-23 receptor(+) T cells in peripheral blood mononuclear cells of patients with systemic lupus erythematosus.
    Puwipirom H; Hirankarn N; Sodsai P; Avihingsanon Y; Wongpiyabovorn J; Palaga T
    Arthritis Res Ther; 2010; 12(6):R215. PubMed ID: 21110900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preserved specific anti-viral T-cell response but associated with decreased lupus activity in SLE patients with cytomegalovirus infection.
    Wu CS; Chyuan IT; Chiu YL; Chen WL; Shen CY; Hsu PN
    Rheumatology (Oxford); 2020 Nov; 59(11):3340-3349. PubMed ID: 32306043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and function of inducible co-stimulator in patients with systemic lupus erythematosus: possible involvement in excessive interferon-gamma and anti-double-stranded DNA antibody production.
    Kawamoto M; Harigai M; Hara M; Kawaguchi Y; Tezuka K; Tanaka M; Sugiura T; Katsumata Y; Fukasawa C; Ichida H; Higami S; Kamatani N
    Arthritis Res Ther; 2006; 8(3):R62. PubMed ID: 16563187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4
    Kosmaczewska A; Ciszak L; Stosio M; Szteblich A; Madej M; Frydecka I; Wiland P; Szmyrka M
    Lupus; 2020 Jun; 29(7):705-714. PubMed ID: 32279585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excessive production of IFN-gamma in patients with systemic lupus erythematosus and its contribution to induction of B lymphocyte stimulator/B cell-activating factor/TNF ligand superfamily-13B.
    Harigai M; Kawamoto M; Hara M; Kubota T; Kamatani N; Miyasaka N
    J Immunol; 2008 Aug; 181(3):2211-9. PubMed ID: 18641361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B7/BB1 provides an important costimulatory signal for CD3-mediated T lymphocyte proliferation in patients with systemic lupus erythematosus (SLE).
    Sfikakis PP; Oglesby R; Sfikakis P; Tsokos GC
    Clin Exp Immunol; 1994 Apr; 96(1):8-14. PubMed ID: 7512010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased CD38 expression in T cells and circulating anti-CD38 IgG autoantibodies differentially correlate with distinct cytokine profiles and disease activity in systemic lupus erythematosus patients.
    Pavón EJ; Zumaquero E; Rosal-Vela A; Khoo KM; Cerezo-Wallis D; García-Rodríguez S; Carrascal M; Abian J; Graeff R; Callejas-Rubio JL; Ortego-Centeno N; Malavasi F; Zubiaur M; Sancho J
    Cytokine; 2013 May; 62(2):232-43. PubMed ID: 23538292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and function of inducible costimulator on peripheral blood T cells in patients with systemic lupus erythematosus.
    Yang JH; Zhang J; Cai Q; Zhao DB; Wang J; Guo PE; Liu L; Han XH; Shen Q
    Rheumatology (Oxford); 2005 Oct; 44(10):1245-54. PubMed ID: 15987711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective B7 expression on antigen-presenting cells underlying T cell activation abnormalities in systemic lupus erythematosus (SLE) patients.
    García-Cózar FJ; Molina IJ; Cuadrado MJ; Marubayashi M; Peña J; Santamaría M
    Clin Exp Immunol; 1996 Apr; 104(1):72-9. PubMed ID: 8603537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brief Report: CD4+ T Cells From Patients With Systemic Lupus Erythematosus Respond Poorly to Exogenous Interleukin-2.
    Comte D; Karampetsou MP; Kis-Toth K; Yoshida N; Bradley SJ; Kyttaris VC; Tsokos GC
    Arthritis Rheumatol; 2017 Apr; 69(4):808-813. PubMed ID: 27992687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased T cell response to anti-CD2 in systemic lupus erythematosus and reversal by anti-CD28: evidence for impaired T cell-accessory cell interaction.
    Horwitz DA; Tang FL; Stimmler MM; Oki A; Gray JD
    Arthritis Rheum; 1997 May; 40(5):822-33. PubMed ID: 9153542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preferential elimination of CD28+ T cells in systemic lupus erythematosus (SLE) and the relation with activation-induced apoptosis.
    Kaneko H; Saito K; Hashimoto H; Yagita H; Okumura K; Azuma M
    Clin Exp Immunol; 1996 Nov; 106(2):218-29. PubMed ID: 8918566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
    Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
    Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of CD30 on CD3 T lymphocytes in patients with systemic lupus erythematosus.
    Cabrera CM; Urra JM; Carreño A; Zamorano J
    Scand J Immunol; 2013 Sep; 78(3):306-12. PubMed ID: 23790231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Study of Interleukin-2 Production and Nck Adaptor Molecule Gene Expression in Systemic Lupus Erythematosus Patients.
    Towiwat P; Buttham B
    J Med Assoc Thai; 2017 Apr; 100(4):396-402. PubMed ID: 29911835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypical changes and clinical significance of CD4
    Yuan S; Zeng Y; Li J; Wang C; Li W; He Z; Ye J; Li F; Chen Y; Lin X; Yu N; Cai X
    Lupus Sci Med; 2022 Jun; 9(1):. PubMed ID: 35732344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The abnormal apoptosis of T cell subsets and possible involvement of IL-10 in systemic lupus erythematosus.
    Wang H; Xu J; Ji X; Yang X; Sun K; Liu X; Shen Y
    Cell Immunol; 2005 Jun; 235(2):117-21. PubMed ID: 16226734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.